ESTRO-ACROP guideline "target delineation of glioblastomas"

Radiotherapy and Oncology

Volumn 118, Issue 1, 2016, Pages 35-42

  Niyazi, Maximilian ^a   Brada, Michael ^b   Chalmers, Anthony J ^c   Combs, Stephanie E ^d   Erridge, Sara C ^e   Fiorentino, Alba ^f   Grosu, Anca L ^g   Lagerwaard, Frank J ^h   Minniti, Giuseppe ⁱ   Mirimanoff, René Olivier ^j   Ricardi, Umberto ^k   Short, Susan C ^l   Weber, Damien C ^m,n   Belka, Claus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Clinical Cancer Medicine   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^g UNIVERSITY OF FREIBURG   (Germany)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

^j UNIVERSITY OF LAUSANNE   (Switzerland)

^k UNIVERSITY OF TURIN   (Italy)

^l ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^m PAUL SCHERRER INSTITUTE   (Switzerland)

ⁿ UNIVERSITY OF ZURICH   (Switzerland)

more..

Author keywords

ACROP; Delineation; ESTRO; Glioblastoma; Radiotherapy; Target volume

Indexed keywords

ARTICLE; CANCER RECURRENCE; CONSENSUS; EUROPE; GLIOBLASTOMA; GLIOMA; HUMAN; IMAGE GUIDED RADIOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; TREATMENT PLANNING; TUMOR VOLUME; ADULT; ADVISORY COMMITTEE; BRAIN NEOPLASMS; PROCEDURES; RADIOTHERAPY PLANNING SYSTEM; TUMOR RECURRENCE;

ADULT; ADVISORY COMMITTEES; BRAIN NEOPLASMS; EUROPE; GLIOBLASTOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 84959510460     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.12.003     Document Type: Article

References (50)

1. D. Amelio, S. Lorentini, M. Schwarz, and M. Amichetti Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues Radiother Oncol 97 2010 361 369
2. F. Ataman, P. Poortmans, R. Stupp, B. Fisher, and R.O. Mirimanoff Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review Eur J Cancer 40 2004 1724 1730
3. H. Aydin, I. Sillenberg, and H. von Lieven Patterns of failure following CT-based 3-D irradiation for malignant glioma Strahlenther Onkol 177 2001 424 431
4. R. Bashir, F. Hochberg, and R. Oot Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields Neurosurgery 23 1988 27 30
5. J. Boda-Heggemann, C. Walter, A. Rahn, and et al. Repositioning accuracy of two different mask systems-3D revisited: comparison using true 3D/3D matching with cone-beam CT Int J Radiat Oncol Biol Phys 66 2006 1568 1575
6. E.L. Chang, S. Akyurek, T. Avalos, and et al. Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma Int J Radiat Oncol Biol Phys 68 2007 144 150
7. B.W. Corn, M. Wang, S. Fox, and et al. Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03 J Neurooncol 95 2009 247 257
8. W.J. Curran Jr., C.B. Scott, J. Horton, and et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials J Natl Cancer Inst 85 1993 704 710
9. B. Emami, J. Lyman, A. Brown, and et al. Tolerance of normal tissue to therapeutic irradiation Int J Radiat Oncol Biol Phys 21 1991 109 122
10. L.E. Gaspar, B.J. Fisher, D.R. Macdonald, and et al. Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment Int J Radiat Oncol Biol Phys 24 1992 55 57
11. M.R. Gilbert, M. Wang, K.D. Aldape, and et al. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial J Clin Oncol 31 2013 4085 4091
12. I. Gotz, and A.L. Grosu [(18)F]FET-PET imaging for treatment and response monitoring of radiation therapy in malignant glioma patients - a review Front Oncol 3 2013 104
13. A. Gregor, A. Cull, E. Traynor, M. Stewart, F. Lander, and S. Love Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters Radiother Oncol 41 1996 55 59
14. A.L. Grosu, S.T. Astner, E. Riedel, and et al. An interindividual comparison of O-(2-[18F]fluoroethyl)-l-tyrosine (FET)- and l-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases Int J Radiat Oncol Biol Phys 81 2011 1049 1058
15. E.C. Halperin, G. Bentel, E.R. Heinz, and P.C. Burger Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations Int J Radiat Oncol Biol Phys 17 1989 1347 1350
16. C.F. Hess, J.C. Schaaf, R.D. Kortmann, M. Schabet, and M. Bamberg Malignant glioma: patterns of failure following individually tailored limited volume irradiation Radiother Oncol 30 1994 146 149
17. F.H. Hochberg, and A. Pruitt Assumptions in the radiotherapy of glioblastoma Neurology 30 1980 907 911
18. D.B. Hoelzinger, T. Demuth, and M.E. Berens Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment J Natl Cancer Inst 99 2007 1583 1593
19. B.S. Hoppe, L.D. Stegman, M.J. Zelefsky, and et al. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting-the MSKCC experience Int J Radiat Oncol Biol Phys 67 2007 691 702
20. E.P. Jansen, L.G. Dewit, M. van Herk, and H. Bartelink Target volumes in radiotherapy for high-grade malignant glioma of the brain Radiother Oncol 56 2000 151 156
21. V.S. Jeganathan, A. Wirth, and M.P. MacManus Ocular risks from orbital and periorbital radiation therapy: a critical review Int J Radiat Oncol Biol Phys 79 2011 650 659
22. K. Kristiansen, S. Hagen, T. Kollevold, and et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group Cancer 47 1981 649 652
23. N. Laperriere, L. Zuraw, and G. Cairncross Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review Radiother Oncol 64 2002 259 273
24. Y.R. Lawrence, X.A. Li, I. el Naqa, and et al. Radiation dose-volume effects in the brain Int J Radiat Oncol Biol Phys 76 2010 S20 S27
25. S.W. Lee, B.A. Fraass, L.H. Marsh, and et al. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study Int J Radiat Oncol Biol Phys 43 1999 79 88
26. S. Lorentini, D. Amelio, M.G. Giri, and et al. IMRT or 3D-CRT in glioblastoma? A dosimetric criterion for patient selection Technol Cancer Res Treat 12 2013 411 420
27. A. Malmstrom, B.H. Gronberg, C. Marosi, and et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial Lancet Oncol 13 2012 916 926
28. C. Mayo, E. Yorke, and T.E. Merchant Radiation associated brainstem injury Int J Radiat Oncol Biol Phys 76 2010 S36 S41
29. G. Minniti, D. Amelio, M. Amichetti, and et al. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide Radiother Oncol 97 2010 377 381
30. M. Niyazi, J. Geisler, A. Siefert, and et al. FET-PET for malignant glioma treatment planning Radiother Oncol 99 2011 44 48
31. U. Oppitz, D. Maessen, H. Zunterer, S. Richter, and M. Flentje 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation Radiother Oncol 53 1999 53 57
32. H.H. Pai, A. Thornton, L. Katznelson, and et al. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis Int J Radiat Oncol Biol Phys 49 2001 1079 1092
33. C.C. Pan, A. Eisbruch, J.S. Lee, R.M. Snorrason, Haken.R.K. Ten, and P.R. Kileny Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients Int J Radiat Oncol Biol Phys 61 2005 1393 1402
34. J.T. Parsons, F.J. Bova, C.R. Fitzgerald, W.M. Mendenhall, and R.R. Million Radiation retinopathy after external-beam irradiation: analysis of time-dose factors Int J Radiat Oncol Biol Phys 30 1994 765 773
35. S. Rieken, D. Habermehl, F.L. Giesel, and et al. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy Radiother Oncol 109 2013 487 492
36. W. Roa, P.M. Brasher, G. Bauman, and et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial J Clin Oncol 22 2004 1583 1588
37. N.A. Rosenfelder, L. Corsini, H. McNair, and et al. Comparison of setup accuracy and intrafraction motion using stereotactic frame versus 3-point thermoplastic mask-based immobilization for fractionated cranial image guided radiation therapy Pract Radiat Oncol 3 2013 171 179
38. F. Sahm, D. Capper, A. Jeibmann, and et al. Addressing diffuse glioma as a systemic brain disease with single-cell analysis Arch Neurol 69 2012 523 526
39. R.S. Scheibel, C.A. Meyers, and V.A. Levin Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment J Neurooncol 30 1996 61 69
40. S. Scoccianti, B. Detti, D. Gadda, and et al. Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist's guide for delineation in everyday practice Radiother Oncol 114 2015 230 238
41. R. Stupp, M. Brada, M.J. van den Bent, J.C. Tonn, and G. Pentheroudakis High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 25 2014 93 101
42. R. Stupp, M.E. Hegi, T. Gorlia, and et al. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial Lancet Oncol 15 2014 1100 1108
43. R. Stupp, M.E. Hegi, W.P. Mason, and et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
44. R. Stupp, W.P. Mason, M.J. van den Bent, and et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
45. M.D. Walker, E. Alexander Jr., W.E. Hunt, and et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial J Neurosurg 49 1978 333 343
46. M.D. Walker, S.B. Green, D.P. Byar, and et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery N Engl J Med 303 1980 1323 1329
47. M.D. Walker, T.A. Strike, and G.E. Sheline An analysis of dose-effect relationship in the radiotherapy of malignant gliomas Int J Radiat Oncol Biol Phys 5 1979 1725 1731
48. K.E. Wallner, J.H. Galicich, G. Krol, E. Arbit, and M.G. Malkin Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma Int J Radiat Oncol Biol Phys 16 1989 1405 1409
49. D.C. Weber, T. Zilli, F. Buchegger, and et al. [(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma Radiat Oncol 3 2008 44
50. W. Wick, M. Platten, C. Meisner, and et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial Lancet Oncol 13 2012 707 715